ÂÜÀòÂÒÂ×

Marc Criton is an experienced executive in the health and biotechnology sectors, currently serving as Chief Operating Officer at CYTEA BIO since August 2020 and Chief Executive Officer at MedXCell SA since November 2019. Criton's prior roles include Senior Project Manager in Business Development at SATT AxLR from April 2013 to November 2019, and extensive leadership positions at Laboratoires Mayoly Spindler, including Active Pharmaceutical Ingredients Manager and R&D Deputy Director, spanning from 1996 to 2013. Academic credentials include a PhD in Organic and Analytical Chemistry from the University of Montpellier and advanced degrees in Quality and Business Administration from Université Paris Cité and IAE Montpellier.